The turnover of voltage-operated calcium channels was studied in two different human neuroblastoma cell lines (IMR32 and SH-SY5Y) using w-conotoxin.
The 1251-o-conotoxin bound to surface channels was internalized and degraded by the cells in a time-and temperature-dependent manner. The radioactive degradation products released in the medium were all trichloroacetic acid soluble and no longer recognized by anti-w-conotoxin antibodies.
Altering the pH of intracellular organelles with chloroquine and inhibiting lysosomal proteases with leupeptin reduced '%w-conotoxin degradation but had no effect on its internalization. Postlabeling measurements showed that the rates of 1251-o-conotoxin internalization and degradation were equal to the rate of channel removal from the cell surface after protein synthesis inhibition.
The rate of removal of o-conotoxin binding sites was parallel to the rate of loss of functional channels, as measured by means of the furatechnique. Drug-induced differentiation of human neuroblastoma cells slowed down channel internalization and degradation rates, leading to the known increased expression of plasma membrane calcium channels in differentiated cells. On the other hand, both human (from Lambert-Eaton myasthenic patients) and murine (from immunized mice) anti-channel antibodies increased the rates of channel internalization and degradation, leading to channel downregulation. The activity of presynaptic calcium channels is already known to be acutely modulated by a number of different agents (e.g., hormones and neurotransmitters); our studies suggest that a different form of channel modulation (changes in the number of channels due to interference with channel turnover) may be active over a longer time scale in neurons. This form of modulation could be important in both physiological and pathological states.
A crucial ion channel on the plasma membrane of nerve terminals is the voltage-operated calcium channel (VOCC), which, upon depolarization, opens its pore and allows calcium ions to enter the nerve terminal along their electrochemical gradient, thus triggering neurotransmitter release by exocytosis. Although a lot of information is available on the functional and pharmacological properties of neuronal VOCCs (for recent reviews, see Bean, 1989; Hess, 1990; Sher et al., 1991) , few reports have been published on the cellular mechanisms controlling VOCC expression, subcellular localization, and tumover in neuronal cells.
VOCC expression has been shown to change during in vitro neuronal differentiation (Streit and Lux, 1989; Carbone et al., 1990; Usowicz et al., 1990) , and a subcellular compartmentalization of specific VOCC subtypes in different domains of the plasma membrane has recently been demonstrated (Ahlidanian et al., 1990; Robitaille et al., 1990; Westenbroek et al., 1990; Cohen et al., 1991; Torri Tarelli et al., 1991) , but the cellular mechanisms underlying these processes are still poorly characterized. This is mainly due to the previous lack of specific ligands and suitable in vitro cellular systems for studying VOCC metabolism.
We have now overcome this problem by using the calcium channel antagonist w-conotoxin (w-ctx) in human neuroblastoma cell lines expressing a sufficient number of VOCCs.
Neuroblastoma cells have already been shown to be a useful cellular model for studying the pharmacology and physiology of human neuronal VOCCs (Sher et al., 1988; Carbone et al., 1990) . Furthermore, these cells have the interesting properties of developing a secretory apparatus after exposure to differentiating agents (Sher et al., 1989a) , and of forming cholinergic synapses when cocultured with muscle cells (Thompson et al., 1982) .
w-Ctx is a peptide neurotoxin present in the venom of fishhunting marine snails of the Conus genus, which has been recently shown to block selectively one subtype of the high-voltage-activated calcium channels present in neurons and other secretory cells (Olivera et al., 1990; Sher and Clementi, 199 1) . We (Toni Tarelli et al., 199 1) and others (Robitaille et al., 1990; Cohen et al., 1991) have shown that w-ctx-sensitive VOCCs (also referred to as w-type VOCCs) are clustered in the presynaptic active zones; this, together with a number of other functional data (reviewed in Miller, 1987; Sher and Clementi, 199 l) , suggests that this VOCC subtype plays a critical role in controlling neurotransmitter release.
This article describes the general properties of w-type VOCC turnover and demonstrates that it can be modulated during cellular differentiation or by pathological events.
Although information has long been available on the metab-olism of other membrane ion channels, such as the nicotinic ACh receptor (Fambrough, 1979) and, to a lesser extent, the voltage-operated sodium channel (Sherman and Catterall, 1984; Bar-Sagi and Prives, 1985; Dargent and Couraud, 1990) , this is the first detailed study of the metabolism of a neuronal VOCC subtype.
Materials and Methods Cell culture and di&erentiation
The IMR32 cell line (ATCC CCL127) was obtained from the American Type Culture Collection (Rockville, MD), and grown and differentiated as previously described (Sher et al., 1989a) .
The SH-SYSY cell line (Pahlman et al.. 1984) was kindly provided by Dr. M. Toselli (University of Pavia). These cells were grownin RPM1 1640 medium supplemented with 10% fetal calf serum, 100 III/ml penicillin, and 100 &ml streptomycin. Their differentiation was achieved by adding a final concentration of 10 PM retinoic acid freshly dissolved in ethanol directly in the dishes.
The cells were kept at 37°C in a humidified incubator at a 5% CO, concentration in air. For immunoprecipitation experiments, the cells were grown to confluency in Falcon lOO-mm-diameter plastic Petri dishes; for turnover experiments, the cells were plated at a concentration of 3 x lo5 in 35-mm-diameter dishes and used after the indicated times.
'251-w-ctx binding assay
In order to be able to perform experiments on intact adherent cells, a modification of a previously described binding assay protocol (Sher et al., 1988) was used. Cells grown in 35-mm-diameter dishes were washed twice with Dulbecco's modified phosphate-buffered saline containing 0.1% bovine serum albumin (DPBS-BSA) 1 ml/dish. 'Z51-w-ctx was added to either the DPBS-BSA or the culture medium at the indicated concentrations (usually 25, 50, or 100 PM) and left on the cells for 2 hr at room temperature. After five washes with DPBS-BSA, 1 ml/dish, to remove unbound toxin, the cells were extracted in 1 ml of 1N NaOH and bound radioactivity was determined by means of a Beckman 74000 gamma-counter. Each binding point was evaluated on triplicate dishes. Nonspecific 1251-w-ctx binding was evaluated for every group by incubating three parallel dishes in the presence of an excess (200 nM) of unlabeled toxin. Under these conditions, nonspecific lZ51-W-ctx binding was = 15% of total binding.
12"I-w-ctx-VOCC complex degradation
In order to study the degradation ofprebound 1Z51-w-ctx, different groups of dishes were washed and labeled as described above. In each group, total and nonspecific binding were evaluated in triplicate. One group was extracted as described above in order to evaluate specific 'ZSI-w-ctx binding at time 0. The other groups were returned to the incubator at 37°C (or at the temperatures indicated in the figures) in the presence of control culture medium. In some experiments, the culture medium was supplemented with drugs (see figure captions) . At the indicated times, a single group ofdishes was recovered; the medium was collected, centrifuged, and counted to determine released radioactivity; and the cells were extracted to determine the amount of remaining cell-associated radioactivity.
1251-w-ctx-VOCC complex internalization
In order to measure 1251-W-ctx cell internalization, we used an acid wash procedure similar to the one described in other models of receptor internalization (Vuk-Pavlovic and Kovach, 1989) .
We first determined the buffer and pH conditions that allowed us to detach the greatest amount of surface-bound 'Z51-W-ctx without altering cell viability. Two 5 min washes with 0.5 ml of a 1% acetic acid buffer, pH 3, detached -90% of surface-bound '2SI-w-ctx without significantly altering cell viability (trypan blue exclusion indicated that < 5% of the cells were killed). Higher pH values did not detach bound 1251-W-ctx, and longer incubations increased cell mortality (not shown).
To determine '251-W-ctx internalization rates, the cells were labeled as described above and returned to the incubator in the presence of control culture medium or one of the different agents to be tested. At the indicated times, a single group ofcells was recovered and the medium collected and counted to determine lZ51-W-ctx degradation. The cells were then washed with the acid buffer, which was collected, centrifuged, and counted in order to determine the amount of "acid-releasable" lZ51-w-ctx (i.e., still on the cell surface). The cells were then extracted as described above in order to determine the amount of "acid-resistant" 1251-W-ctx (i.e., internalized).
Characterization of released radioactivity TCA experiments. A protocol similar to that described by Paul et al. (1989) was used to characterize released radioactivity and to test whether this really represented the degradation of 'ZSI-w-ctx (a 27 amino acid peptide) into smaller components.
In a total volume of 300 ~1 of culture medium, we added either native 1251-W.CtX (50 PM, -3000 cpm/ml) or -3000 cpm of the radioactivity contained in the medium of the cells incubated for 24 hr at 37°C after the labeling procedure (putative degraded '2SI-w-ctx). Parallel controls were performed by adding identical amounts of radioactivity corresponding to native 1251-W-ctx incubated 24 hr at 37°C in the absence of cells, but either with control culture medium, or with "conditioned medium" (i.e., medium collected from routinely cultured IMR32 cells, in which putative released proteolytic enzymes might be present). A 1 mg/ml concentration of BSA was added to each tube as carrier protein, followed by a 10% final concentration of cold trichloroacetic acid (TCA). After overnight incubation at 4"C, the tubes were centrifuged (10 min at 10,000 rpm), the pellets counted in a gamma-counter, and the percentage of TCA-insoluble radioactivity determined.
Immu~oprecipitation with anti-w-ctx antibodies. In the presence of control rabbit serum to ensure a constant IgG level in each tube, increasing concentrations of a rabbit anti-o-ctx antiserum were added to a fixed amount of native "'1-w-Ctx (50 PM, -3000
or to a similar amount of radioactivity released in the medium by prelabeled cells, or related to the controls described above for TCA experiments. After overnight incubation at 4°C 35 ~1 of goat anti-rabbit IgG antibodies were added to each tube. After an additional 2 hr at room temperature, the tubes were centrifuged, and the pellets washed once with DPBS-BSA and then counted.
Antisera
The production and properties of the anti-w-ctx antiserum were described in a previous article (Toni Tarelli et al., 199 1) . Lambert-Eaton myasthenic syndrome (LEMS) sera were obtained from patients with clinically diagnosed disease.
Mouse anti-w-type VOCC antibodies were obtained by intraperitoneally immunizing C57 black mice with intact neuroblastoma cells (~0.5 ml/injection, = 5 x 10" cells/ml) or unrelated cells as control. After four injections (l/week), the serum was collected and the ant&-type VOCC antibody titer determined as described below.
w-Type VOCC immunoprecipitation
The titer of anti-w-type VOCC antibodies in both LEMS and mouse sera was determined by a radioimmunometric procedure we have recently developed (Sher et al., 1989b) .
Briefly, a large number of neuroblastoma cells (~40 x 106/ml) was homogenized in a buffer consisting of 0.3 M sucrose, 5 mM HEPES/ Tris, pH 7.4, supplemented with 0.01 mg/ml lysozyme, 1 mg/ml BSA, 0.5 mM phenylmethylsulfonyl fluoride, 2 FM leupeptin, and 1 PM pepstatin A. A saturating concentration (100 PM) of 1251-W-ctx was added for 2 hr at room temperature. lZSI-w-ctx-VOCC complexes were then solubilized by the addition of Triton X-100 (1% final concentration). After 3 hr at 4°C the sample was centrifuged for 30 min at 15,000 rpm in a Sorvall RB centrifuge and the supematant used as the source of antigen. Increasing concentrations of either LEMS or mouse serum were added to a constant volume of supematant in the presence of control human or mouse serum as a carrier. After overnight incubation at 4°C 50 ~1 of either rabbit anti-human IgG or goat anti-mouse IgG solutions were added to each tube. After 2 additional hours at room temperature, the samples were centrifuged, the pellets washed, and the amount of precipitated radioactivity counted in a gamma-counter. The antibody titer was determined from the linear part of the precipitation curve and expressed as picomoles of 'ZSI-w-ctx binding sites precipitated/liter of serum.
[C'a2% measurements with jiira-2 A protocol similar to the one previously described (Sher et al., 1988) was used for studying the depolarization-induced increase in [Ca*+], and its reduction after protein synthesis blockade with cycloheximide. Brief- Figure I . Degradation and internalization of 1Z51-w-ctx by prelabeled cells. The figure shows the fraction of cell-associated radioactivity remaining at different times after labeling surface VOCCs with 1251-W-ctx (25 PM). Each time point is the average of five 35 mm culture dishes and represents the binding and degradation of only specifically bound toxin from both IMR32 (a) and Sk-SY5Y (0) cells. Specific ';SI-W-ctx binding at time 0 was 1660 cpm/dish for IMR32 and 2525 cpm/dish for SH-SYSY cells. In these particular experiments, the degradation half-lives for IMR32 and SH-SYSY cells were, respectively, 19.6 and 15.9 hr. Inset, The fraction of radioactivity associated with the cell surface (acid releasable) is evaluated at different times after labeling surface VOCCs with 'Ww-ctx (25 PM). In these particular experiments, the internalization half-lives for IMR32 and SH-SYSY cells were, respectively, 18.2 and 15.2 hr.
ly, at different times after addition of cycloheximide, IMR32 cells were aentlv detached from the dish, washed once in Krebs-Ringer-HEPES solution (containing 125 mM NaCl, 5 rnM KCl, 12 mM MgSO,, 1.2 mM KH,PO,. 2 mM CaCl,, 6 mM glucose. and 25 mM HEPES-NaOH (pH 7.4): and then resuspended (10; cells/ml) in the same solution. Loading of the cells with fura-was achieved by incubating the cell suspension with 2.5 PM fura-acetoxymethyl ester for 30 min at 37°C. Fluorescent measurements (excitation and emission, respectively, at 345 and 490 nm) were made in a spectrofluorometer using a thermostatically controlled cell holder equipped for continuous stirring. Calibration of the fluorescent signal in terms of [Caz+] , was performed as previously described (Di Virgilio et al., 1987) .
Reagents
Minimum essential medium, RPM1 1640, fetal calf serum, antibiotics, and glutamine were obtained from Flow Labs (Ayrshire, UK). Plastic Falcon petri dishes were purchased from Becton Dickinson (Plymouth, UK). Dibutyryl-5-cyclic monophosphate, 5-bromodeoxyuridine, retinoic acid, BSA, anti-rabbit IgG, anti-human IgG, anti-mouse IgG, leupeptin, pepstatin A, carbachol, and cycloheximide were purchased from Sigma Chemical Co. (St. Louis, MO). Synthetic w-ctx fraction GVIA was obtained from Bachem (Bubendorf, Switzerland), while '151-W-ctx was from Amersham (Amersham, UK). Chloroquine was from Boehringer Mannheim (Germany), and fura-acetoxymethyl ester was from Molecular Probes (Eugene, OR). All other reagents were of reagent grade and were purchased from E. Merck (Darmstadt, Germany).
Results

1251-w-ctx-VOCC complex degradation
In a previous study, we showed that the specific and saturable binding of lZSI-w-ctx to human neuroblastoma cells is essentially irreversible (Sher et al., 1988) . Furthermore, parallel changes in the number of 1251-W-ctx binding sites and in the amount of w-ctx-sensitive calcium currents have been described in different cells (Carbone et al., 1990 ; E. Sher, E. Carbone, E. Biancardi, and F. Clementi, unpublished observations), confirming the validity of using this toxin as a marker for calcium channels. Immunoprecipitation of '*51-w-ctx and its degradation products. Increasing concentrations of anti-toxin antibodies were added either to a fixed amount of native 'ZSI-w-ctx (0) or to the same amount of radioactivity released in the medium by prelabeled cells (0). Antitoxin antibodies precipitated most of the native toxin, but only a small fraction of released radioactivity. Each point was performed in quadruplicate, and similar results were obtained in three independent experiments.
Taking advantage of these properties, intact, living neuroblastoma cells were labeled with 1*51-w-ctx, and after extensive washing, the fate ofthe irreversibly bound toxin at 37°C was followed, as an indirect estimate of w-type VOCC turnover. Similar "prelabeling" protocols have already been fruitfully used for the study of nicotinic ACh receptor turnover in both muscle (Devreotes and Fambrough, 1975) and chromaffin cells (Higgins and Berg, 1988) .
VOCC turnover was evaluated by measuring both the radioactivity released in the medium and that remaining associated with the cells in groups of dishes recovered at different times after labeling.
Specifically bound radioactivity (total minus nonspecific) was released in the medium with a monoexponential kinetic. Large quantities of nonspecific radioactivity were released during the first 2 hr at 37°C and in negligible amounts thereafter, thus probably reflecting a washout phenomenon ofthe lZ51-w-ctx nonspecifically bound to the dishes. At 37°C the half-life values of the radioactivity released from the cells were 16.5 + 0.8 hr (mean f SEM; n = 18) and 16 f 1.3 hr (mean + SEM; n = 4) for undifferentiated SH-SYSY and IMR32 cells, respectively (Fig. 1) .
The rate of radioactivity release was not influenced by either the 1Z51-w-ctx concentration used for labeling surface VOCCs (between 10 and 50 PM), or the duration of the labeling step (between 15 and 120 min) (not shown). Furthermore, the presence or absence of fetal calf serum in the medium did not acutely affect 1*51-w-ctx degradation rate.
The nature of the released radioactive material was investigated by means of TCA precipitation experiments and with the aid of anti-w-ctx antibodies. TCA (10%) precipitated only a small fraction of the radioactivity released in the medium by prelabeled cells after 24 hr at 37°C (= 10% of the precipitable native 1*51-w-ctx). This demonstrates that most of the released radioactivity is associated with small, TCA-soluble degradation fragments of 1251-W-ctx. Native 1Z51-w-ctx, incubated for 24 hr at 37°C in the absence of cells but in the presence of either fresh or "conditioned" medium, was not degraded and could still be precipitated to the same degree as native '251-w-ctx (not shown). Anti-w-ctx antibodies were able to precipitate more than 90% of the radioactivity due to native 1251-W-ctx, but precipitated less than 10% of the same amount of radioactivity collected after [Cal+], increase still available after blocking protein synthesis with cycloheximide as evaluated at different times. The half-life for loss of functional CaZ+ channels was 15.6 hr. Each point represents the average of five independent determinations.
24 hr at 37°C from the medium of prelabeled cells (Fig. 2) . More than 80% of the 1*51-w-ctx incubated for 24 hr at 37°C with either fresh culture or "conditioned" medium was still precipitable by the antibodies (not shown).
This result indicates that most of the radioactivity released in the medium by prelabeled cells at 37°C is related to the proteolysis of 1251-W-ctx, and not simply to its dissociation from the cells.
1z51-w-ctx-VOCC complex internalization
To determine whether 'ZSI-w-ctx degradation was coupled to VOCC internalization, two different strategies were used: acid wash and protein synthesis inhibition. The neuroblastoma cells were prelabeled with lj51-W-ctx and returned to 37°C as described above for the degradation experiments; at the indicated times, the internalized (acid-resistant) and surface-bound (acid-releasable) specific radioactivity was measured.
The half-lives for 1251-w-ctx internalization (in control medium and at 37°C) were 13.5 + 0.6 hr (mean + SEM; n = 11) for undifferentiated SH-SYSY cells and 15.3 * 2.4 hr (mean ? SEM; n = 4) for undifferentiated IMR32 cells (Fig. 1, inset ). These are similar to the half-lives obtained measuring radioactivity release into the medium, which suggests that, at least under control conditions, clearance of 'Z51-w-ctx from the cell surface and radioactivity release may be coupled processes. It was also important to demonstrate that w-type VOCC degradation occurs in parallel to that of the bound 'Z51-w-ctx. Consequently, we studied the time course of both the removal of toxin binding sites from the cell surface and the loss of the depolarization-induced increase in [CaI+] , after protein synthesis was blocked with cycloheximide (postlabeling protocol and furameasurements). Figure 3 shows that, after a lag of ~2 hr, IMR32 cells incubated in the presence of 100 fig/ml cycloheximide lost their toxin binding sites with a half-life of 17.5 k 1.8 hr (mean ? SEM; n = lo), a value similar to the rate of release of radioactivity into the medium by prelabeled cells. The KCl-induced increase in [Ca2+], in IMR32 cells was more than 90% blocked by 100 nM w-ctx but only partially affected by 1 PM verapamil (not shown). Therefore, KCl-induced CaZ+ influx under these conditions can be taken as a good measure of the functional w-type VOCC present on the plasma membrane. Figure 3 (inset) shows that after protein synthesis blockade, the number of functional channels present on the plasma membrane declines with a kinetic similar to the loss of surface toxin binding sites. Also in this case, channel loss started after a lag of -2 hr and the measured half-life was 16.5 hr, similar to the rate of internalization measured with binding techniques. As shown in Table 1 The good agreement between these different values, measured using both binding and fura-techniques, strongly suggests (1) that the release of radioactivity into the medium is a result of 1Z51-w-ctx-VOCC complex degradation and therefore can be taken as an indirect measure of VOCC turnover, and (2) that w-ctx binding per se does not significantly affect VOCC turnover. l?fiect of temperature and lysosomotropic drugs on 1251-w-~t~-VOCC complex internalization and degradation The results shown above are compatible with a model in which the lZSI-w-ctx bound to the channel is internalized by endocytosis and then transported to the lysosomes, where it is hydrolized and the radioactive degradation products are released into the medium. To test this hypothesis further, 1251-w-ctx intemalization and degradation rates were measured in cells exposed to low temperatures or to drugs known to affect the lysosomal degradation of proteins.
lZ51-W-ctx degradation was completely blocked when prelabeled cells were incubated at either 4°C or 20°C (Fig. 4) , whereas lZ51-W-ctx internalization was blocked only at 4"C, and at 20°C the internalization rate remained similar to that of the 37°C control (Fig. 4, inset) . Endosome-lysosome fusion is blocked at < 20°C (Van Deurs et al., 1989) ; therefore, our data suggest that the degradation of the 1251-w-ctx-VOCC complex only occurs after transport to lysosomes.
The incubation of 1Z51-w-ctx prelabeled cells in a medium containing chloroquine, a drug that raises the pH of intracellular organelles, led to a dramatic slowing down of radioactivity release into the medium (Fig. 5) . The effect of chloroquine was dose dependent (not shown). At 37"C, in the presence of 20 PM chloroquine the degradation half-life in IMR32 cells was 47 + 5.9 hr (mean ? SEM; n = 4) (Fig. 5) , significantly longer than in the control. Leupeptin, a selective inhibitor ofacid hydrolases known to affect the lysosomal degradation of other membrane proteins, also reduced 1251-w-ctx degradation in a dose-dependent manner. In the presence of 20 PM leupeptin, the degradation half-life was 38 f 4 hr (mean f SEM; n = 4) (Fig. 6) . While both chloroquine and leupeptin significantly reduced 1251-W-ctx degradation, neither drug affected 1Z51-w-ctx intemalization, which proceeded with rates similar to those of the controls (insets of Figs. 5 and 6, for chloroquine and leupeptin, respectively).
VOCC turnover during neuroblastoma cell d@rentiation We have previously shown that both the number of 'Z51-w-ctx binding sites and that of high-voltage-activated calcium currents increases during in vitro drug-induced neuroblastoma cell differentiation (Carbone et al., 1990 ). An increase in the number of surface channels can be achieved by an increase in protein synthesis and/or protein incorporation in the plasma membrane, or by a slowing down in protein internalization and degradation. To investigate whether channel turnover was modified during differentiation, we carried out experiments with 12s1-~-ctx on differentiated cells.
In IMR32 cells differentiated for 7 d in the presence of 1 mM dibutyryl-5-cyclic monophosphate and 2.5 PM 5-bromodeoxyuridine, the half-life of 1251-W-ctx degradation was increased to 45 f 5 hr (mean * SEM; n = 3) (Fig. 7) . No acute changes in the degradation rate were observed during the first 24 hr of culture in the presence of the differentiating agents. The increase in half-life was gradual and developed over several days of exposure to the drugs (16.8, 37.6, 45, and 63 hr after, respectively, 1, 3, 7, and 15 d). Similar results were obtained in SH-SYSY cells differentiated for several days in the presence of 10 PM retinoic acid (not shown).
As indicated by the acid wash experiments, the metabolic stability of VOCCs induced by cell differentiation was primarily due to a direct effect on the cellular mechanisms controlling VOCC internalization, which was significantly slowed down in differentiated cells (Fig. 7, inset) , rather than to changes in the efficiency of the differentiated lysosomal apparatus. Figure 7 . 12SI-W-Ctx degradation and internalization in differentiated neuroblastoma cells. Both '251-W-ctx degradation and internalization (inset) rates were slowed in differentiated (0) versus control (0) IMR32 cells. At time 0, 1251-w-ctx-specific binding was 1667 cpm/dish in control cells and 5282 cpm/dish in differentiated cells. In these particular experiments, the degradation rates were 15.5 and 45.0 hr, and the internalization rates were 15.0 and 41.6 hr. for control and differentiated (for 7 d) cells, respectively.
I?flects of anti-channel antibodies on VOCC turnover
In LEMS, autoantibodies are produced against presynaptic w-type VOCCs (Sher et al., 1989b) , and these antibodies are known to affect the number and function of VOCCs in different in vivo and in vitro preparations (Vincent et al., 1989) . Two sets ofanti-VOCC antibodies were used in order to study any effects they might have on VOCC turnover: one source of antibodies was the serum of LEMS patients; the other was the serum of mice immunized with intact neuroblastoma cells as described in Materials and Methods. Both antisera contained antibodies capable of precipitating 1251-w-ctx-labeled VOCCs . Degradation of 12SI-w-ctx-VOCC complexes in human neuroblastoma cells exposed to different anti-VOW antisera. IMR32 cells were prelabeled with 12SI-W-ctx, and the radioactivity released in the medium after I hr at 37°C was determined as described in Materials and Methods. Values represent the percentage of radioactivity released with respect to that specifically bound at time 0 (average -C SE; n = 3). IMR32 cells were incubated in the presence of a 10% concentration of either fetal calf serum (a), control human serum (6), LEMS serum (c), control mouse serum (4, or immunized mouse serum (e).
extracted from IMR32 cells (Fig. 8) . The anti-w-type VOCC antibody titer was 110 PM in LEMS serum and 80 PM in immunized mouse serum.
Both sera increased receptor turnover: in cells treated with LEMS serum, the half-life of lZ51-w-ctx degradation was 11 -t 1.2 hr (mean + SEM; n = 3) versus the 17 + 2 hr (mean ? SEM; n = 5) of cells incubated in the presence of control human serum; in cells treated with mouse antiserum, the half-life of '251-W-ctx degradation was 14 ? 0.8 hr (mean ? SEM; n = 3) versus the 19 f 1.5 hr (mean +-SEM; n = 5) of cells incubated in the presence of control mouse serum. The effect of the anti-VOCC antibodies was rapid: after only 1 hr of exposure to the antisera, a greater amount of radioactivity was released into the medium by prelabeled cells than by control cells (Fig. 9) . The increased degradation of lZ51-w-ctx induced by anti-VOCC antibodies was completely prevented by coincubation with 20 PM chloroquine (not shown), thus indicating that both normal VOCC turnover (see above) and antibody-accelerated VOCC turnover occur in similar intracellular, acidic organelles.
Discussion
Synaptic activity is subject to both rapid regulatory events and more slowly developing adaptation processes. One of the molecular targets of these processes is the VOCC, a membrane protein that plays a crucial role in the control of cell excitability, neurotransmitter release, synaptogenesis, and synaptic pathology (Bean, 1989; Hess, 1990; Sher et al., 199 1) .
VOCC activity is acutely modulated by events such as phosphorylation/dephosphorylation or by interaction (via G-proteins) with other membrane receptors (Carbone and Swandulla, 1989) . These rapid modulatory events occur, and revert, within a time scale of a few milliseconds.
On a relatively longer time scale, a synapse might modulate its function by up-or downregulating the actual number ofVOCCs expressed on the plasma membrane.
In a number of tissues, VOCC expression is subject to both (Ferrante and Triggle, 1990) . In particular, neuronal high-voltage-activated calcium channels are known to be upregulated in differentiating neurons (Streit and Lux, 1989; Carbone et al., 1990; Usowicz et al., 1990) to be concentrated in the growth cones (Lipscombe et al., 1988; Silver et al., 1990; Reber and Reuter, 1991) and to be clustered in the presynaptic active zones of mature synapses (Robitaille et al., 1990; Cohen et al., 1991; Torri Tarelli et al., 1991) .
In order to obtain more information on the processes regulating VOCC expression, an in vitro model system combining the use of human neuroblastoma cells and w-ctx was adopted. Most of the experiments reported in this article were performed by following the fate of 1251-W-ctx prebound to the cells because our results indicate that this is identical to the fate of the w-type vocc:
(1) The degradation half-life of specifically bound toxin is very similar to the half-life of toxin binding site removal from the plasma membrane in cycloheximide-treated cells. (2) The loss oftoxin binding sites from the plasma membrane is parallel to the loss of functional Ca2+ channels measured with the fura-technique in cycloheximide-treated cells. (3) A pH as low as pH 3 is necessary to detach a significant amount of specifically bound toxin from the cell surface, making it highly unlikely that the toxin dissociates from the channel in endosomes or other intracellular organelles whose internal pH is between 4 and 6.
(4) The appearance of radioactivity in the medium and the corresponding loss of cell-associated radioactivity are clearly a consequence of the metabolic processes of the cell itself and not of the dissociation of prebound tZ51-w-ctx or nonspecific toxin degradation because the radioactivity in the medium was found to be associated with toxin degradation products and, furthermore, its catabolism was blocked by reducing the temperature, by increasing the pH of intracellular organelles, and by blocking lysosomal proteases.
(5) Antibodies against w-type VOCCs (from both LEMS patients and from immunized mice) increased l*SI-w-ctx catabolism, and this accelerated catabolism was slowed by chloroquine in the same way as in cells not treated with antibody. The metabolism of w-type VOCCs in neurons is similar in many respects to that of muscle nicotinic receptors (Fambrough, 1979) . The calculated VOCC internalization and degradation half-lives are similar to those obtained in vitro for other membrane ion channels, such as the nicotinic receptor (Devreotes and Fambrough, 1975 ) and the voltage-operated sodium channel (Sherman and Catterall, 1984; Bar-Sagi and Prives, 1985; Dargent and Couraud, 1990 ). This suggests that there is a general feature that underlies the turnover of this particular class of membrane proteins.
The mechanisms behind the increased expression of plasma membrane w-type VOCCs in differentiated neurons are particularly interesting, because this could be achieved by different mechanisms alternatively influencing protein synthesis or degradation. Both possibilities have been described in the case of muscle nicotinic receptors: the increased expression of extrajunctional nicotinic receptors in developing myotubes has been shown to be due to increased synthesis, with no changes in the degradation rate (Devreotes and Fambrough, 1975) ; and the increased expression of junctional nicotinic ACh receptors induced by CAMP and CAMP analogs in denervated muscles has been found to be caused by a decrease in the receptor degradation rate (Shyng et al., 199 1) .
By using different and unrelated differentiating drugs in two different human neuroblastoma cell lines, we have found that the morphological differentiation of the cells was accompanied by a parallel decrease in VOCC catabolism that was due to reduced channel internalization. The molecular mechanisms of this "stabilization" are still unknown, although posttranslational channel modifications (e.g., phosphorylations), changes in channel subunit composition, and the induction of specific interactions with the cytoskeleton are all possibilities worth investigating.
VOCC turnover was slowed down during differentiation, but it could also be pathologically accelerated. LEMS autoantibodies and mouse anti-w-type VOCC antibodies induced an increased internalization and degradation of w-type VOCCs. At the cellular level, these results confirm previous suggestions that LEMS autoantibodies may act by cross-linking VOCCs (Nagel et al., 1988) and thus inducing VOCC downregulation (Sher et al., 1989b; Leys et al., 1991) .
The antibody effects described here were more rapid than might be expected from the results of previous studies conceming the effects of antibodies on 45Ca2+ influx (Roberts et al., 1985; De Aizpurua et al., 1988) or VOCC downregulation (Sher et al., 1989b; Leys et al., 1991) , probably because the present experiments studied the selective effects of the antibodies on prelabeled channels, without the interference of newly incorporated channels.
LEMS antibody-induced VOCC downregulation has already been shown to be specific in comparison with other membrane molecules (Sher et al., 1989b) , a highly selective, antibody-induced downregulation of membrane receptors and ion channels being a common feature of a number of human autoimmune disorders (Clementi and Sher, 1987) .
